ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

The Company is filing this amendment to the Original 8-K to provide (i) (A) the unaudited pro forma condensed combined consolidated balance sheets of Mesa Labs as of September 30, 2019, (B) the unaudited pro forma condensed combined consolidated statements of operations of the Company for the year ended March 31, 2019, (C) the unaudited pro forma condensed combined consolidated statements of income of the Company for the six months ended September 30, 2019, (D) the related notes to unaudited pro forma condensed combined consolidated financial statements; (ii) the audited financial statements of GPT, which comprise (A) the balance sheets as of December 31, 2018 and December 31, 2017; (B) the related statements of income, comprehensive income, stockholders' equity, and cash flows for the years then ended, and (C) the related notes to the financial statements; and (iii) the unaudited financial statements of GPT, which comprise (A) the unaudited balance sheets as of June 30, 2019; (B) the related unaudited statements of income, comprehensive income, stockholders' equity, and cash flows for the six months ended June 30, 2019 and 2018, respectively; and (C) the related notes to the financial statements.

Exhibit No. Description



23.1          Consent of Plante & Moran, PLLC dated January 15, 2020.

99.2          (A) Unaudited pro forma condensed combined consolidated balance
            sheets of the Company as of September 30, 2019, (B) the unaudited pro
            forma condensed combined consolidated statement of operations of the
            Company for the year ended March 31, 2019, (C) the unaudited pro
            forma condensed combined consolidated statements of income of the
            Company for six months ended September 30, 2019, (D) the related
            notes to unaudited pro forma condensed combined consolidated
            financial statements

99.3          Audited financial statements of Gyros Protein Technologies Holding
            AB, which comprise (A) the balance sheets as of December  31, 2018
            and 2017; (B) the related statements of income, comprehensive income,
            stockholders' equity, and cash flows for the years then ended; and
            (C) the related notes to the financial statements

99.4          Unaudited financial statements of Gyros Protein Technologies
            Holding AB, which comprise (A) the balance sheet as of June 30, 2019;
            (B) the related statements of income, comprehensive income,
            stockholders' equity, and cash flows for the six months ended June
            30, 2019 and June 30, 2018, respectively; and  (C) the related notes
            to the financial statements.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses